Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vopr Pitan ; 92(2): 97-108, 2023.
Artigo em Russo | MEDLINE | ID: mdl-37346025

RESUMO

Bovine colostrum (ВС) has a high biological value, which allows it to be used for the development of new functional products. The aim of the study was to assess the possibility of using BC for the prevention and treatment of infectious and non-infectious diseases. Material and methods. The search for scientific information on the study of the component composition, immunobiological properties and the use of BC in clinical practice was carried out using the databases of the RSCI, CyberLeninka, ScienceDirect, PubMed. Results. The macro- and micronutrient composition of BC is presented, its changes over time from the moment of calving are described. A comparative analysis of the content of various components in milk and colostrum is presented. A detailed list of antimicrobial factors that increase nonspecific resistance and provide immunocorrective, antimicrobial and anti-inflammatory effects is submitted. The possibility of using BC in clinical practice as a part of complex therapy in the treatment of various infectious diseases, including severe acute respiratory syndrome caused by the new coronavirus infe ction SARS-CoV-2, as well as in cardiovascular diseases, allergies, autoimmune and oncological diseases, has been demonstrated. Conclusion. According to the literature, BC has a high safety profile and is applicable to all age groups of the population. Given the wide range of biological activity of BC components, a promising area of scientific research is the development of the products for therapeutic and prophylactic purposes, including dietary supplements, based on its ingredients, which have the desired properties for correcting the immune status, preventing non-communicable and infectious diseases, as well as for prevention of occupational diseases among persons working in harmful working conditions.


Assuntos
COVID-19 , Colostro , Feminino , Gravidez , Bovinos , Animais , SARS-CoV-2 , Leite , Suplementos Nutricionais
2.
Vestn Ross Akad Med Nauk ; (7-8): 30-7, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25563002

RESUMO

Long-term stress as well as physiological aging result in similar immunological and hormonal disturbances including hypothalamic-pituitary-adrenal) axis depletion, aberrant immune response (regulatory T-cells, Tregs, and T(h17)-lymphocyte accumulation) and decreased dehydroepian-drosterone synthesis both in the brain and in the adrenal glands. Since the main mechanisms of inflammation control, "prompt" (stress hormones) and "delayed" (Tregs), are broken, serum cytokine levels increase and become sufficient for blood-brain-barrier disruption. As a result peripheral cytokines penetrate into the brain where they begin to perform new functions. Structural and functional alterations of blood-brain-barrier as well as stress- (or age-) induced neuroinflammation promote influx of bone marrow derived dendritic cells and lymphocyte effectors into the brain parenchyma. Thereafter, mass intrusion ofpro-inflammatory mediators and immune cells having a lot of specific targets alters the brain work that we can observe both in humans and in animal experiments. The concept of stressful cognitive dysfunction, which is under consideration in this review, allows picking out several therapeutic targets: 1) reduction of excessive Treg accumulation; 2) supporting hypothalamic-pituitary-adrenal axis and inflammatory reaction attenuation; 3) recovery of dehydroepiandrosterone level; 4) improvement of blood-brain-barrier function.


Assuntos
Adjuvantes Imunológicos/farmacologia , Envelhecimento , Encéfalo , Transtornos Cognitivos , Doenças do Sistema Imunitário , Estresse Fisiológico/imunologia , Linfócitos T Reguladores , Adaptação Fisiológica , Adaptação Psicológica/fisiologia , Envelhecimento/efeitos dos fármacos , Envelhecimento/fisiologia , Bloqueadores do Receptor Tipo 2 de Angiotensina II/farmacologia , Animais , Encéfalo/patologia , Encéfalo/fisiologia , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/prevenção & controle , Citocinas/metabolismo , Desidroepiandrosterona/farmacologia , Humanos , Sistema Hipotálamo-Hipofisário/metabolismo , Doenças do Sistema Imunitário/etiologia , Doenças do Sistema Imunitário/metabolismo , Macrolídeos/farmacologia , Sistema Hipófise-Suprarrenal/metabolismo , Linfócitos T Reguladores/patologia , Linfócitos T Reguladores/fisiologia
3.
Vestn Ross Akad Med Nauk ; (6): 38-44, 2006.
Artigo em Russo | MEDLINE | ID: mdl-16869260

RESUMO

The problem of constructing means of correction of gastrointestinal microflora is utterly important. The most promising direction here seems to be construction of synbiotics containing a multiprobiotic complex of bifidobacteria and lactobacilli, modeling the microbiocenosis of a certain age group, inulin, as a prebiotic factor and a vitamin and mineral complex. The aim of the study was to evaluate the biologically active food supplement "Normospectrum" vs. the commercial preparation "Bifidumbacterin", its ability to correct the intestinal microflora and the functional condition of the gastrointestinal tract in children. "Normospectrum" was well tolerated, favored regression of the main clinical manifestations, and had positive effect on the intestinal microbiocenosis, increasing the proportion of bifidobacteria, lactobacilli and escherichiae with full enzymatic activity, and lowering the proportion of conditionally pathogenic bacteria and fungi in the intestinal tract. The effects of "Normospectrum" on the functional disturbances of the gastrointestinal tract and the intestinal microflora were much more profound than those of "Bifidumbacterin". Good tolerance and positive effects of the new probiotic preparation "Normospectrum" on the intestinal microbiosis allows recommending it for broad clinical application in children when correction of dysbiotic shifts in the intestinal microflora is necessary.


Assuntos
Suplementos Nutricionais , Gastroenteropatias/tratamento farmacológico , Probióticos/uso terapêutico , Produtos Biológicos/uso terapêutico , Humanos , Guias de Prática Clínica como Assunto , Resultado do Tratamento
4.
Artigo em Russo | MEDLINE | ID: mdl-16438387

RESUMO

The data contained in literature and obtained in our own investigations, aimed at the evaluation of the significance of interferon preparations for the correction of immunological disturbances are presented. A special place is given to the role of mild medicinal forms of interferon, the necessity of their use is grounded and good prospects for their inclusion into the complex therapy of infectious diseases are shown.


Assuntos
Antivirais/uso terapêutico , Doenças Transmissíveis/tratamento farmacológico , Interferons/uso terapêutico , Adjuvantes Farmacêuticos , Administração Tópica , Animais , Antivirais/administração & dosagem , Doenças Transmissíveis/imunologia , Enema , Humanos , Injeções , Interferon Tipo I/administração & dosagem , Interferon Tipo I/uso terapêutico , Interferons/administração & dosagem , Proteínas Recombinantes , Supositórios
5.
Artigo em Russo | MEDLINE | ID: mdl-12886634

RESUMO

Experiments on 75 monkeys, 20--healthy and 75--with diarrhea, showed that ready medicinal forms of the complex immunoglobulin preparation in tablets, capsules or in a dried form (vials) were safe, well tolerated, clinically and bacteriologically effective. When used simultaneously with antiparasitic treatment, this preparation, irrespective of the kind of its ready medicinal form, showed high curative effect (80-90%). The diarrhea ceasing was accompanied by the gradual normalization of intestinal microbiocenosis (an increased concentrations of Escherichia coli and Bifidobacterium, a decreased amount of opportunistic bacteria). The complex method of the treatment of diarrhea in monkeys (antibiotics, trichopol, phage and probiotics) made it possible to achieve curative effect only in 60% of cases, which required the additional course of treatment, namely the use of rehydration therapy.


Assuntos
Diarreia/tratamento farmacológico , Imunoglobulinas/uso terapêutico , Animais , Anticorpos Antibacterianos/farmacologia , Anticorpos Antibacterianos/uso terapêutico , Anticorpos Antivirais/farmacologia , Anticorpos Antivirais/uso terapêutico , Composição de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Tolerância a Medicamentos , Haplorrinos , Imunoglobulinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA